Results 261 to 264 of about 15,233 (264)

A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors

Ca-A Cancer Journal for Clinicians
exaly  

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial

Ca-A Cancer Journal for Clinicians
exaly  

[PARP (poly(ADP-ribose) polymerase) family].

Nihon rinsho. Japanese journal of clinical medicine, 2013
Hiroko, Saito, Yoshio, Miki
openaire   +1 more source

Poly(ADP‐Ribose) Polymerase (PARP)–1

2005
openaire   +1 more source